Cyanocobalamin Patent Expiration
Cyanocobalamin is Used for treating vitamin B12 deficiencies through nasal administration of cyanocobalamin. It was first introduced by Merck And Co Inc
Cyanocobalamin Patents
Given below is the list of patents protecting Cyanocobalamin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nascobal | US7229636 | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
Aug 01, 2024
(Expired) | Endo Operations |
| Nascobal | US7879349 | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
Aug 01, 2024
(Expired) | Endo Operations |
| Nascobal | US8003353 | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
Aug 01, 2024
(Expired) | Endo Operations |
| Nascobal | US9415007 | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
Jul 28, 2024
(Expired) | Endo Operations |
| Nascobal | US7404489 | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
Mar 12, 2024
(Expired) | Endo Operations |
| Nascobal | US8940714 | Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
Feb 26, 2024
(Expired) | Endo Operations |
Cyanocobalamin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List